The Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Small Business Assistance Program is pleased to inform you of a unique opportunity for small business entities to learn more about the FDA and basic drug regulation. Our webinar series will highlight various aspects of drug regulation.
These focused webinars will support the Program’s mission of promoting productive interaction with regulated industry by assisting regulated domestic and international small pharmaceutical business with information relating to the development and regulation of human drug products.
On Monday, March 19, 2012, we presented our webinar entitled FDA’s Medical Countermeasures initiative (MCMi) and You, which described FDA’s Medical Countermeasures initiative (MCMi) and explained what we are doing under the initiative to support the development and availability of medical products.
Our presenter was Dr. Luciana Borio, who is Assistant Commissioner for Counterterrorism Policy and Director of the Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Commissioner. Dr. Borio joined FDA in 2008 coming from the Center for Biosecurity at the University of Pittsburgh Medical Center (UPMC), where she served from 2003 to 2008 as Senior Associate, Assistant Professor of Medicine at the University of Pittsburgh, and Advisor on Biodefense Programs to the U.S. Department of Health and Human Services (HHS).
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.